Home Cart Sign in  
Chemical Structure| 500577-51-5 Chemical Structure| 500577-51-5

Structure of Cyclo(-RGDfK) TFA
CAS No.: 500577-51-5

Chemical Structure| 500577-51-5

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Cyclo(-RGDfK) Trifluoroacetate is a highly potent and selective inhibitor for the αvβ3 integrin with a IC50 of 0.94 nM.

Synonyms: Cyclo

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Cyclo(-RGDfK) TFA

CAS No. :500577-51-5
Formula : C29H42F3N9O9
M.W : 717.69
SMILES Code : O=C(O)C(F)(F)F.O=C(O)C[C@@H](C(N[C@H](CC1=CC=CC=C1)C(N[C@@H](CCCCN)C(N[C@@H](CCCNC(N)=N)C(NC2)=O)=O)=O)=O)NC2=O
Synonyms :
Cyclo
MDL No. :MFCD20488083
InChI Key :WHCQIPJAWCYHFT-HXSCNMCGSA-N
Pubchem ID :91759592

Safety of Cyclo(-RGDfK) TFA

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Related Pathways of Cyclo(-RGDfK) TFA

cytoskeleton

Isoform Comparison

Biological Activity

Target
  • Integrin

In Vitro:

Cell Line
Concentration Treated Time Description References
Human podocytes 1 μM 24 h Inhibited ITGB3 activity and alleviated podocyte injury PMC6534572
human podocytes 1 μM 24 h Inhibited ITGB3 activity and alleviated podocyte injury PMC6534572

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
Mice Podocyte-specific miR-30 sponge transgenic mice Intravenous injection 10 mg/kg Every 8 hours for a total of 3 times Inhibited ITGB3 activity and alleviated proteinuria and podocyte injury PMC6534572
Mice Podocyte-specific miR-30 sponge transgenic mice Intravenous injection 10 mg/kg Every 8 hours for a total of 3 times Inhibited ITGB3 activity and alleviated proteinuria and podocyte injury PMC6534572

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

1.39mL

0.28mL

0.14mL

6.97mL

1.39mL

0.70mL

13.93mL

2.79mL

1.39mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2
The prepared working fluid is recommended to be prepared now and used up as soon as possible in a short period of time. The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1

References

 

Historical Records

Categories